NCT06207500

Brief Summary

Background: Transitions of care often lead to medication errors and unnecessary healthcare utilisation. It has been repeatedly shown that medication reconciliation can at least partially reduce this risk. Objective: The aim of this prospective pragmatic trial was to evaluate the effectiveness of pharmacist-led medication reconciliation offered to medical patients as part of routine clinical practise. The main questions to be answered were:

  • the effectiveness of pharmacist-led medication reconciliation on medication discrepancies at discharge and 30 days after discharge
  • the effectiveness of pharmacist-led medication reconciliation on healthcare utilisation within 30 days after discharge. Participants in the intervention group were offered the following:
  • medication reconciliation on admission
  • medication reconciliation on discharge, coupled with patient counselling, provided by clinical pharmacists. Participants in the control group were offered standard care.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
553

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2019

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 30, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 18, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

December 22, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

January 17, 2024

Completed
Last Updated

January 17, 2024

Status Verified

January 1, 2024

Enrollment Period

1.1 years

First QC Date

December 22, 2023

Last Update Submit

January 12, 2024

Conditions

Keywords

medication errorunplanned healthcare utilisationtransitions of carepharmacistpatient dischargepatient counselling

Outcome Measures

Primary Outcomes (1)

  • Unplanned healthcare utilisation within 30 days after discharge

    Unplanned healthcare utilisation within 30 days of hospital discharge was defined as any unplanned visit to a general practitioner, specialist, emergency department (ED), or hospitalisation or death. The visits were classified as unplanned, if sudden health problems required medical attention, and planned, if scheduled. Data on mortality due to any reason were also collected 30 days after discharge. For each patient, only the most detrimental outcome was classified.

    within 30 (±5) days after hospital discharge

Secondary Outcomes (4)

  • Serious unplanned healthcare utilisation within 30 days after discharge

    within 30 (±5) days after hospital discharge

  • Clinically important medication errors at discharge

    On the day of hospital discharge (up to 365 days from hospital admission)

  • Medication discrepancies at 30 days

    At 30 (±5) days after hospital discharge

  • All healthcare utilisation within 30 days after discharge

    within 30 (±5) days after hospital discharge

Study Arms (2)

Intervention Group

ACTIVE COMPARATOR

Patients were offered pharmacist- led medication reconciliation on admission and discharge coupled with patient counselling.

Procedure: Pharmacist-led Medication Reconciliation

Control Group

NO INTERVENTION

Patients received standard care - only written instructions on discharge medications in the discharge letter, according to the standard practice.

Interventions

The best possible medication history (BPMH) at hospital admission was obtained from medical and pharmacy records and by interviewing the patient or carers. The BPMH - an accurate and complete (or as close as possible) list of medications the patient is currently taking - was documented in the medication information system. At hospital admission the BPMH was compared with the therapy in hospital to identify discrepancies. All discrepancies were discussed with the treating physician, unintentional discrepancies were reconciled. Intentional discrepancies were documented in the medical records. Prior to discharge from hospital, the BPMH and the medications planned in the discharge therapy were compared again to ensure that all unintentional discrepancies were corrected. Intentional discrepancies were explained in the discharge letter. Individual patient counselling on discharge medications and pharmacotherapy changes was conducted and coupled with written instructions in lay language.

Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All adult medical patients admitted to the study wards

You may not qualify if:

  • patients who do not speak Slovenian,
  • transferred from another ward,
  • previously included in the same study.
  • patients hospitalised only for diagnostic purposes,
  • patients transferred to another ward or hospital,
  • patients that died during hospitalisation,
  • patients from the control group who were offered medication reconciliation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Clinic of Respiratory and Allergic Diseases Golnik

Golnik, Select State, 4202, Slovenia

Location

Related Publications (1)

  • Jost M, Kerec Kos M, Kos M, Knez L. Effectiveness of pharmacist-led medication reconciliation on medication errors at hospital discharge and healthcare utilization in the next 30 days: a pragmatic clinical trial. Front Pharmacol. 2024 Mar 28;15:1377781. doi: 10.3389/fphar.2024.1377781. eCollection 2024.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Pragmatic prospective controlled clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Pharmacist

Study Record Dates

First Submitted

December 22, 2023

First Posted

January 17, 2024

Study Start

September 30, 2019

Primary Completion

October 18, 2020

Study Completion

December 31, 2020

Last Updated

January 17, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations